CytoDyn Financial Overview
CytoDyn's market cap is currently $358.59M. The company's EPS TTM is $-0.009; its P/E ratio is -15.60; CytoDyn is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.